Decreased production of AmpC-type beta-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains. 1999

M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
Department of Clinical Sciences, School of Medicine, University of Las Palmas de G.C., Spain.

The effect of fluoroquinolones in Citrobacter freundii strains that results in a decreased expression of cephalosporin-hydrolysing beta-lactamases was studied. Resistance to broad-spectrum cephalosporins and penicillins in two C. freundii clinical isolates was associated with moderate production of chromosomal AmpC-type-beta-lactamase in addition to changes in the outer membrane proteins profile with respect to wild-type C. freundii strains. Ten quinolone-resistant mutants were derived from the two clinical isolates using increasing fluoroquinolone concentrations. The level of susceptibility to cephalosporins and meropenem of these 10 mutants was increased and was associated with a 3.6-32% diminution in the hydrolyzing activity of their periplasmic extracts containing beta-lactamases on cephaloridine as compared with those from their parent strains. Susceptibility to cephalosporins and meropenem, as well as the expression of chromosomal AmpC-type-beta-lactamase in C. freundii strains, was influenced by the exposure to quinolones.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D016971 Citrobacter freundii A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen. Bacterium freundii,Citrobacter ballerupensis,Escherichia freundii,Salmonella ballerup,Salmonella hormaechei
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
May 2002, Antimicrobial agents and chemotherapy,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
July 1985, Proceedings of the National Academy of Sciences of the United States of America,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
May 1986, European journal of biochemistry,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
October 2006, The Journal of antimicrobial chemotherapy,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
February 1983, Antimicrobial agents and chemotherapy,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
January 2002, Antimicrobial agents and chemotherapy,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
June 1988, Antimicrobial agents and chemotherapy,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
October 1998, The Journal of antimicrobial chemotherapy,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
December 1984, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
M M Tavío Pérez, and G Amicosante, and N Franceschini, and J Vila, and J Ruiz, and A Oratore, and A M Martín-Sánchez, and M T Jiménez de Anta
July 1991, Molecular microbiology,
Copied contents to your clipboard!